Skip to content

Study on the mechanism of MEBT/MEBO repair in regulating ERK1/2 and p38 signaling pathways based on miRNA-mRNA network study

Study on the mechanism of MEBT/MEBO repair in regulating ERK1/2 and p38 signaling pathways based on miRNA-mRNA network study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200066660
Enrollment
Unknown
Registered
2022-12-13
Start date
2022-12-20
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetic foot ulcer

Interventions

blank control group:The wounds are washed with hydrogen peroxide and saline and then treated with complexed iodine disinfection
negative control group:The wounds are washed with hydrogen peroxide and saline and then treated with complexed iodine disinfection
conventional group:The wounds were washed with hydrogen peroxide and normal saline and replaced with complex iodine yarn
MEBO group:Wounds are washed with hydrogen peroxide, saline, complexed with iodine, then MEBO, yarn dressing

Sponsors

Youjiang Medical University for Nationalities/ The Affiliated Hospital of Youjiang Medical University for Nationalities
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria for diabetic foot group: age 40-65 years; Refractory diabetic foot ulcer for more than 1 month; ABI in 0.5 to 0.9; Wagner is a 2-3 grader. The inclusion criteria of the control group were 40-65 years old; No history of diabetes; Contusion or cutting injury below the knee plane within one week; ABI 0.9 or higher.

Exclusion criteria

Exclusion criteria: untreated cellulitis, malignant wounds; There was significant necrotic tissue or osteomyelitis; Complicated with serious cardiovascular and cerebrovascular diseases, liver and kidney function damage, hematological diseases, autoimmune diseases, tumors, etc. Subjects who received growth factor or hyperbaric oxygen therapy 30 days before or during the study period.

Design outcomes

Primary

MeasureTime frame
miRNA expression profile;mRNA expression profile;

Countries

China

Contacts

Public ContactBIAO LIANG WU

The Affiliated Hospital of Youjiang Medical University for Nationalities

yymucun@ymun.edu.cn13977621889

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 9, 2026